Protein container, polynucleotide, vector, expression cassette, cell, method for producing container, method for pathogen recognition or disease diagnosis, use of container, and diagnostic kit
A technology of protein and protein structure, applied in the application of pharmacy and biotechnology, falling into the field of chemistry, preparation, and medicine, can solve the problems of unproved simultaneous expression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
no. 1 approach
[0124] In a first embodiment, the invention relates to a diagnostic kit comprising a protein container as defined above.
[0125] Finally, the invention is described in detail by the examples given hereinafter. It should be emphasized that the present invention is not limited to these embodiments, and it also includes changes and modifications within the range that can be developed. It is also worth noting that the authorized use of all biological sequences of the Brazilian genetic heritage is registered with SISGEN under registration number AC53976.
Embodiment 1
[0127] Example 1 -Container protein construction
[0128] Amino acid sequences between different instances of green fluorescent protein, eGFP (GenBank: L29345.1; UniProtKB-P42212), Cycle-3 (GenBank: CAH64883.1), SuperFolder (GenBank: AOH95453.1), Split (Cabantous et al. Reports 3:2854, 2013), Superfast (Fisher&DeLisa.PLoS One 3:e2351, 2008), used to construct the new protein of the present invention. Sequence alignment and comparison were performed by Intaglio software (Purgatory Design, V3.9.4). From these data, certain changes were made so that the container protein could achieve the desired properties.
[0129] Changes were made to create restriction enzyme sites. The insertion of these sites was designed such that the physicochemical properties of the GFP protein could not be altered, thus not affecting the properties or qualities described in this patent application. Furthermore, the insertion of these restriction sites will allow the genetic manipulation of these pr...
Embodiment 2
[0197] Example 2 – Construction of the PlatCruzi protein
[0198] The "platform" container protein was genetically engineered to possess T. cruzi epitopes, which we refer to herein as the PlatCruzi platform. The gene corresponding to the PlatCruzi protein, referred to herein as the PlatCruzi gene, is described in the nucleotide sequence of SEQ ID NO:17.
[0199] Considering experimental data on the specificity and sensitivity of a diagnostic test for Chagas disease, a polyamino acid sequence derived from Trypanosoma cruzi was selected from available prior art literature (Peralta JM et al. J Clin Microbiol 32:971- 974,1994; Houghton RL et al. J Infect Dis 179:1226-1234,1999; Thomas et al. Clin Exp Immunol 123:465-471,2001; Rabello et al., 1999; Gruber & Zingales, Exp Parasitology, 76(1):1-12,1993 ; Lafaille et al., Molecular Biochemistry Parasitology, 35(2):127-36, 1989). The 10 multiple amino acid sequences referred to herein as TcEp1 to TcEp10 were selected for insertion ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com